Frequently Ask Questions
Glau-Vue Ophthalmic, Inc FAQs
What is Glau-Vue Ophthalmic?
Glau-Vue Ophthalmic is a medical device company created to develop and market ophthalmic products and procedures to treat eye disorders worldwide. Its initial product is the Glau-Sert™ device to treat open angle glaucoma.
What is the Glau-Sert?
The Glau-Sert is a patent pending device that treats open angle glaucoma. Glaucoma results from a buildup of fluid pressure in the eye that damages the optic nerve.
How does the Glau-Sert work?
The Glau-Vue Ophthalmic system consists of a device, called a Glau-Sert, attached to the external surface of the patient’s eye using an inserter, markers and a Glau-Ring™. The design of the device reduces intraocular pressure (IOP) by changing the anatomy of the eye. A set of four Glau-Serts is placed in each eye during a 30-minute outpatient surgical procedure under local anesthetics using a Glau-Ring, a disposable inserter.
What makes the Glau-Sert unique?
How does the Glau-Sert device compare to other treatments for glaucoma?
Does the procedure require special training?
What are the requirements for maintaining the Glau-Serts?
What are the risks associated with the Glau-Vue system?
How do the risk factors compare with those of other treatments and modalities?
Is a specialized facility needed to perform the procedure?
No, the 30-minute procedure can be performed in an ophthalmologist’s office under local anesthetic.
